mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |